213 related articles for article (PubMed ID: 22173904)
1. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.
Setó-Salvia N; Pagonabarraga J; Houlden H; Pascual-Sedano B; Dols-Icardo O; Tucci A; Paisán-Ruiz C; Campolongo A; Antón-Aguirre S; Martín I; Muñoz L; Bufill E; Vilageliu L; Grinberg D; Cozar M; Blesa R; Lleó A; Hardy J; Kulisevsky J; Clarimón J
Mov Disord; 2012 Mar; 27(3):393-9. PubMed ID: 22173904
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
Goker-Alpan O; Lopez G; Vithayathil J; Davis J; Hallett M; Sidransky E
Arch Neurol; 2008 Oct; 65(10):1353-7. PubMed ID: 18852351
[TBL] [Abstract][Full Text] [Related]
4. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
[TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase mutations in primary parkinsonism.
Asselta R; Rimoldi V; Siri C; Cilia R; Guella I; Tesei S; Soldà G; Pezzoli G; Duga S; Goldwurm S
Parkinsonism Relat Disord; 2014 Nov; 20(11):1215-20. PubMed ID: 25249066
[TBL] [Abstract][Full Text] [Related]
7. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
[TBL] [Abstract][Full Text] [Related]
8. Association of glucocerebrosidase mutations with dementia with lewy bodies.
Clark LN; Kartsaklis LA; Wolf Gilbert R; Dorado B; Ross BM; Kisselev S; Verbitsky M; Mejia-Santana H; Cote LJ; Andrews H; Vonsattel JP; Fahn S; Mayeux R; Honig LS; Marder K
Arch Neurol; 2009 May; 66(5):578-83. PubMed ID: 19433657
[TBL] [Abstract][Full Text] [Related]
9. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Mata IF; Samii A; Schneer SH; Roberts JW; Griffith A; Leis BC; Schellenberg GD; Sidransky E; Bird TD; Leverenz JB; Tsuang D; Zabetian CP
Arch Neurol; 2008 Mar; 65(3):379-82. PubMed ID: 18332251
[TBL] [Abstract][Full Text] [Related]
10. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DM; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E
JAMA Neurol; 2013 Jun; 70(6):727-35. PubMed ID: 23588557
[TBL] [Abstract][Full Text] [Related]
11. High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.
Shiner T; Mirelman A; Gana Weisz M; Bar-Shira A; Ash E; Cialic R; Nevler N; Gurevich T; Bregman N; Orr-Urtreger A; Giladi N
JAMA Neurol; 2016 Dec; 73(12):1448-1453. PubMed ID: 27723861
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease in patients and obligate carriers of Gaucher disease.
Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
[TBL] [Abstract][Full Text] [Related]
13. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
[TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients.
Jamrozik Z; Lugowska A; Slawek J; Kwiecinski H
J Neurol; 2010 Mar; 257(3):459-60. PubMed ID: 19882201
[No Abstract] [Full Text] [Related]
15. Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.
Moran EE; Wang C; Katz M; Ozelius L; Schwartz A; Pavlovic J; Ortega RA; Lipton RB; Zimmerman ME; Saunders-Pullman R
Neurobiol Aging; 2017 Oct; 58():239.e1-239.e7. PubMed ID: 28728889
[TBL] [Abstract][Full Text] [Related]
16. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
[TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.
Creese B; Bell E; Johar I; Francis P; Ballard C; Aarsland D
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):232-241. PubMed ID: 28548708
[TBL] [Abstract][Full Text] [Related]
18. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: A meta-analysis.
Zhang Y; Chen J; Xu C; Feng J; Li J
Neurosci Lett; 2020 Jan; 714():134544. PubMed ID: 31672490
[TBL] [Abstract][Full Text] [Related]
20. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
